| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Outcomes of anatomical versus functional testing for coronary artery disease.
|
N Engl J Med
|
2015
|
8.70
|
|
2
|
ACCF/ACR/SCCT/SCMR/ASNC/NASCI/SCAI/SIR 2006 appropriateness criteria for cardiac computed tomography and cardiac magnetic resonance imaging: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American College of Radiology, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, American Society of Nuclear Cardiology, North American Society for Cardiac Imaging, Society for Cardiovascular Angiography and Interventions, and Society of Interventional Radiology.
|
J Am Coll Cardiol
|
2006
|
7.77
|
|
3
|
ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology Endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography.
|
J Am Coll Cardiol
|
2009
|
7.36
|
|
4
|
Effect of phosphodiesterase-5 inhibition on exercise capacity and clinical status in heart failure with preserved ejection fraction: a randomized clinical trial.
|
JAMA
|
2013
|
4.85
|
|
5
|
Appropriateness of percutaneous coronary intervention.
|
JAMA
|
2011
|
4.33
|
|
6
|
Renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R(2)CHADS(2) index in the ROCKET AF (Rivaroxaban Once-daily, oral, direct factor Xa inhibition Compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (AnTicoagulation and Risk factors In Atrial fibrillation) study cohorts.
|
Circulation
|
2012
|
4.10
|
|
7
|
Association between physician billing and cardiac stress testing patterns following coronary revascularization.
|
JAMA
|
2011
|
3.19
|
|
8
|
Obstructive coronary atherosclerosis and ischemic heart disease: an elusive link!
|
J Am Coll Cardiol
|
2012
|
2.93
|
|
9
|
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery. A report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Developed in collaboration with the American Association for Thoracic Surgery, Society of Cardiovascular Anesthesiologists, and Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2011
|
2.84
|
|
10
|
Rivaroxaban compared with warfarin in patients with atrial fibrillation and previous stroke or transient ischaemic attack: a subgroup analysis of ROCKET AF.
|
Lancet Neurol
|
2012
|
2.77
|
|
11
|
International variation in and factors associated with hospital readmission after myocardial infarction.
|
JAMA
|
2012
|
2.75
|
|
12
|
Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.
|
Ann Intern Med
|
2007
|
2.69
|
|
13
|
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2011
|
2.69
|
|
14
|
ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 Appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography.
|
J Am Coll Cardiol
|
2012
|
2.68
|
|
15
|
Percutaneous coronary interventions and cardiovascular outcomes for patients with chronic total occlusions.
|
Catheter Cardiovasc Interv
|
2011
|
2.56
|
|
16
|
Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE Quality Improvement Initiative.
|
Am Heart J
|
2005
|
2.55
|
|
17
|
2011 ACCF/AHA guideline for coronary artery bypass graft surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
J Thorac Cardiovasc Surg
|
2012
|
2.40
|
|
18
|
Prevention of stroke and systemic embolism with rivaroxaban compared with warfarin in patients with non-valvular atrial fibrillation and moderate renal impairment.
|
Eur Heart J
|
2011
|
2.31
|
|
19
|
ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2013
|
2.29
|
|
20
|
2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Circulation
|
2011
|
2.24
|
|
21
|
ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance. Endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine.
|
J Am Soc Echocardiogr
|
2007
|
1.96
|
|
22
|
ACCF/ASNC appropriateness criteria for single-photon emission computed tomography myocardial perfusion imaging (SPECT MPI): a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group and the American Society of Nuclear Cardiology endorsed by the American Heart Association.
|
J Am Coll Cardiol
|
2005
|
1.88
|
|
23
|
Patterns of cardiac stress testing after revascularization in community practice.
|
J Am Coll Cardiol
|
2010
|
1.88
|
|
24
|
Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains.
|
Circulation
|
2012
|
1.81
|
|
25
|
Quality of care for atrial fibrillation among patients hospitalized for heart failure.
|
J Am Coll Cardiol
|
2009
|
1.81
|
|
26
|
Cardiologist concordance with the American College of Cardiology appropriate use criteria for cardiac testing in patients with coronary artery disease.
|
Am J Cardiol
|
2012
|
1.70
|
|
27
|
Appropriate use criteria to reduce underuse and overuse: striking the right balance.
|
J Am Coll Cardiol
|
2012
|
1.69
|
|
28
|
ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine.
|
J Am Coll Cardiol
|
2008
|
1.62
|
|
29
|
Outcomes of temporary interruption of rivaroxaban compared with warfarin in patients with nonvalvular atrial fibrillation: results from the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF).
|
Circulation
|
2014
|
1.54
|
|
30
|
Arteriotomy closure devices for cardiovascular procedures: a scientific statement from the American Heart Association.
|
Circulation
|
2010
|
1.53
|
|
31
|
Ischaemic cardiac outcomes in patients with atrial fibrillation treated with vitamin K antagonism or factor Xa inhibition: results from the ROCKET AF trial.
|
Eur Heart J
|
2013
|
1.53
|
|
32
|
Ionizing radiation exposure to patients admitted with acute myocardial infarction in the United States.
|
Circulation
|
2010
|
1.50
|
|
33
|
ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 appropriateness criteria for transthoracic and transesophageal echocardiography: a report of the American College of Cardiology Foundation Quality Strategic Directions Committee Appropriateness Criteria Working Group, American Society of Echocardiography, American College of Emergency Physicians, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society for Cardiovascular Magnetic Resonance endorsed by the American College of Chest Physicians and the Society of Critical Care Medicine.
|
J Am Coll Cardiol
|
2007
|
1.44
|
|
34
|
Detection of left ventricular thrombus by delayed-enhancement cardiovascular magnetic resonance prevalence and markers in patients with systolic dysfunction.
|
J Am Coll Cardiol
|
2008
|
1.41
|
|
35
|
Sharing Data from Cardiovascular Clinical Trials - A Proposal.
|
N Engl J Med
|
2016
|
1.34
|
|
36
|
Temporal trends and geographic variation of lower-extremity amputation in patients with peripheral artery disease: results from U.S. Medicare 2000-2008.
|
J Am Coll Cardiol
|
2012
|
1.33
|
|
37
|
Achieving quality in cardiovascular imaging: proceedings from the American College of Cardiology-Duke University Medical Center Think Tank on Quality in Cardiovascular Imaging.
|
J Am Coll Cardiol
|
2006
|
1.29
|
|
38
|
Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.
|
J Am Heart Assoc
|
2013
|
1.26
|
|
39
|
Hospital variability in the rate of finding obstructive coronary artery disease at elective, diagnostic coronary angiography.
|
J Am Coll Cardiol
|
2011
|
1.24
|
|
40
|
Outcomes after cardioversion and atrial fibrillation ablation in patients treated with rivaroxaban and warfarin in the ROCKET AF trial.
|
J Am Coll Cardiol
|
2013
|
1.23
|
|
41
|
Life expectancy and cause of death in males and females with Fabry disease: findings from the Fabry Registry.
|
Genet Med
|
2009
|
1.20
|
|
42
|
Downstream procedures and outcomes after stress testing for chest pain without known coronary artery disease in the United States.
|
Am Heart J
|
2012
|
1.20
|
|
43
|
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2012
|
1.19
|
|
44
|
ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance: endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine.
|
Circulation
|
2008
|
1.11
|
|
45
|
ACCF/SCAI/STS/AATS/AHA/ASNC/HFSA/SCCT 2012 appropriate use criteria for coronary revascularization focused update: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiovascular Computed Tomography.
|
J Thorac Cardiovasc Surg
|
2012
|
1.09
|
|
46
|
2013 ACCF/ACR/ASE/ASNC/SCCT/SCMR appropriate utilization of cardiovascular imaging in heart failure: a joint report of the American College of Radiology Appropriateness Criteria Committee and the American College of Cardiology Foundation Appropriate Use Criteria Task Force.
|
J Am Coll Cardiol
|
2013
|
1.07
|
|
47
|
Evaluating the Diagnostic Performance of Noninvasive Testing and the Perils of Inclusion Bias.
|
JACC Cardiovasc Interv
|
1
|
1.06
|
|
48
|
Appropriate use of cardiovascular technology: 2013 ACCF appropriate use criteria methodology update: a report of the American College of Cardiology Foundation appropriate use criteria task force.
|
J Am Coll Cardiol
|
2013
|
1.04
|
|
49
|
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2017 Appropriate Use Criteria for Coronary Revascularization in Patients With Stable Ischemic Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2017
|
1.02
|
|
50
|
Achieving Quality in Cardiovascular Imaging II: proceedings from the Second American College of Cardiology -- Duke University Medical Center Think Tank on Quality in Cardiovascular Imaging.
|
JACC Cardiovasc Imaging
|
2009
|
1.02
|
|
51
|
Design and rationale of the Reduction of Infarct Expansion and Ventricular Remodeling with Erythropoietin after Large Myocardial Infarction (REVEAL) trial.
|
Am Heart J
|
2010
|
1.00
|
|
52
|
The case of the disappearing myxoma.
|
J Cardiovasc Magn Reson
|
2005
|
0.96
|
|
53
|
Changes in patterns of coronary revascularization strategies for patients with acute coronary syndromes (from the CRUSADE Quality Improvement Initiative).
|
Am J Cardiol
|
2007
|
0.96
|
|
54
|
Predicting chronic left ventricular dysfunction 90 days after ST-segment elevation myocardial infarction: An Assessment of Pexelizumab in Acute Myocardial Infarction (APEX-AMI) Substudy.
|
Am Heart J
|
2010
|
0.94
|
|
55
|
The role of cardiovascular MRI in heart failure and the cardiomyopathies.
|
Cardiol Clin
|
2007
|
0.94
|
|
56
|
Intracranial hemorrhage among patients with atrial fibrillation anticoagulated with warfarin or rivaroxaban: the rivaroxaban once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation.
|
Stroke
|
2014
|
0.94
|
|
57
|
High mortality risks after major lower extremity amputation in Medicare patients with peripheral artery disease.
|
Am Heart J
|
2013
|
0.94
|
|
58
|
Hospital percutaneous coronary intervention appropriateness and in-hospital procedural outcomes: insights from the NCDR.
|
Circ Cardiovasc Qual Outcomes
|
2012
|
0.94
|
|
59
|
Efficacy and safety of rivaroxaban in patients with heart failure and nonvalvular atrial fibrillation: insights from ROCKET AF.
|
Circ Heart Fail
|
2013
|
0.93
|
|
60
|
2013 appropriate utilization of cardiovascular imaging: a methodology for the development of joint criteria for the appropriate utilization of cardiovascular imaging by the American College of Cardiology Foundation and American College of Radiology.
|
J Am Coll Cardiol
|
2013
|
0.92
|
|
61
|
Defining optimal research study design for cardiovascular imaging using computed tomography angiography as a model.
|
Am J Cardiol
|
2008
|
0.89
|
|
62
|
Use of alternative methodologies for evaluation of composite end points in trials of therapies for critical limb ischemia.
|
Am Heart J
|
2012
|
0.88
|
|
63
|
Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry Registry.
|
Genet Med
|
2013
|
0.87
|
|
64
|
Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes.
|
Am J Cardiol
|
2005
|
0.87
|
|
65
|
The study of LoSmapimod treatment on inflammation and InfarCtSizE (SOLSTICE): design and rationale.
|
Am Heart J
|
2012
|
0.86
|
|
66
|
Geographic variation and trends in carotid imaging among medicare beneficiaries, 2001 to 2006.
|
Circ Cardiovasc Qual Outcomes
|
2010
|
0.86
|
|
67
|
Trends in the use of diagnostic coronary angiography, percutaneous coronary intervention, and coronary artery bypass graft surgery across North Carolina.
|
Am Heart J
|
2011
|
0.86
|
|
68
|
Clinical outcomes with rivaroxaban in patients transitioned from vitamin K antagonist therapy: a subgroup analysis of a randomized trial.
|
Ann Intern Med
|
2013
|
0.86
|
|
69
|
Cardiovascular complications of breast cancer therapy in older adults.
|
Oncologist
|
2011
|
0.85
|
|
70
|
Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
|
Eur Heart J
|
2009
|
0.85
|
|
71
|
Rivaroxaban, an oral direct factor Xa inhibitor.
|
Expert Opin Investig Drugs
|
2008
|
0.85
|
|
72
|
Relationship between time in therapeutic range and comparative treatment effect of rivaroxaban and warfarin: results from the ROCKET AF trial.
|
J Am Heart Assoc
|
2014
|
0.85
|
|
73
|
The role of cardiovascular MRI in heart failure and the cardiomyopathies.
|
Magn Reson Imaging Clin N Am
|
2007
|
0.85
|
|
74
|
Diagnosing acute myocardial infarction in patients with left bundle branch block.
|
Am J Cardiol
|
2011
|
0.84
|
|
75
|
ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.
|
J Nucl Cardiol
|
2014
|
0.84
|
|
76
|
End of study transition from study drug to open-label vitamin K antagonist therapy: the ROCKET AF experience.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
0.83
|
|
77
|
Detecting obstructive coronary disease with CT angiography and noninvasive fractional flow reserve.
|
JAMA
|
2012
|
0.83
|
|
78
|
Wearable Cardioverter-Defibrillator Therapy for the Prevention of Sudden Cardiac Death: A Science Advisory From the American Heart Association.
|
Circulation
|
2016
|
0.82
|
|
79
|
ACC/AATS/AHA/ASE/ASNC/SCAI/SCCT/STS 2016 Appropriate Use Criteria for Coronary Revascularization in Patients With Acute Coronary Syndromes: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and the Society of Thoracic Surgeons.
|
J Am Coll Cardiol
|
2016
|
0.82
|
|
80
|
EPC mobilization after erythropoietin treatment in acute ST-elevation myocardial infarction: the REVEAL EPC substudy.
|
J Thromb Thrombolysis
|
2013
|
0.81
|
|
81
|
A meta-analysis and systematic review of computed tomography angiography as a diagnostic triage tool for patients with chest pain presenting to the emergency department.
|
J Nucl Cardiol
|
2012
|
0.81
|
|
82
|
Prognostic implications of left ventricular end-diastolic pressure during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: Findings from the Assessment of Pexelizumab in Acute Myocardial Infarction study.
|
Am Heart J
|
2013
|
0.81
|
|
83
|
Socioeconomic disparities in the use of cardioprotective medications among patients with peripheral artery disease: an analysis of the American College of Cardiology's NCDR PINNACLE Registry.
|
J Am Coll Cardiol
|
2013
|
0.81
|
|
84
|
ACC/AHA/SCAI/AMA-Convened PCPI/NCQA 2013 Performance Measures for Adults Undergoing Percutaneous Coronary Intervention: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Cardiovascular Angiography and Interventions, the American Medical Association-Convened Physician Consortium for Performance Improvement, and the National Committee for Quality Assurance.
|
Circulation
|
2013
|
0.81
|
|
85
|
2013 ACCF/ACR/ASE/ASNC/SCCT/SCMR appropriate utilization of cardiovascular imaging in heart failure: an executive summary: a joint report of the ACR Appropriateness Criteria ® Committee and the ACCF Appropriate Use Criteria Task Force.
|
J Am Coll Radiol
|
2013
|
0.80
|
|
86
|
Effect of peripheral arterial disease on functional and clinical outcomes in patients with heart failure (from HF-ACTION).
|
Am J Cardiol
|
2011
|
0.80
|
|
87
|
Long-term outcomes of older diabetic patients after percutaneous coronary stenting in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008.
|
J Am Coll Cardiol
|
2012
|
0.80
|
|
88
|
Characteristics and long-term outcomes of percutaneous revascularization of unprotected left main coronary artery stenosis in the United States: a report from the National Cardiovascular Data Registry, 2004 to 2008.
|
J Am Coll Cardiol
|
2012
|
0.80
|
|
89
|
ACCF/AHA/ASE/ASNC/HFSA/HRS/SCAI/SCCT/SCMR/STS 2013 multimodality appropriate use criteria for the detection and risk assessment of stable ischemic heart disease: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.
|
J Card Fail
|
2013
|
0.79
|
|
90
|
ACC/AHA/SCAI/AMA-Convened PCPI/NCQA 2013 performance measures for adults undergoing percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures, the Society for Cardiovascular Angiography and Interventions, the American Medical Association-Convened Physician Consortium for Performance Improvement, and the National Committee for Quality Assurance.
|
J Am Coll Cardiol
|
2013
|
0.79
|
|
91
|
Efficacy and safety of rivaroxaban compared with warfarin in patients with peripheral artery disease and non-valvular atrial fibrillation: insights from ROCKET AF.
|
Eur Heart J
|
2013
|
0.79
|
|
92
|
Special Articles: 2011 ACCF/AHA Guideline for Coronary Artery Bypass Graft Surgery: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.
|
Anesth Analg
|
2011
|
0.79
|
|
93
|
Intra-aortic balloon pump trials: questions, answers, and unresolved issues.
|
Circ Cardiovasc Interv
|
2013
|
0.79
|
|
94
|
Importance of total ischemic time and preprocedural infarct-related artery blood flow in predicting infarct size in patients with anterior wall myocardial infarction (from the CRISP-AMI Trial).
|
Am J Cardiol
|
2013
|
0.79
|
|
95
|
Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction.
|
Circ Cardiovasc Qual Outcomes
|
2012
|
0.79
|
|
96
|
Self-regulation in the era of big data: appropriate use of appropriate use criteria.
|
Ann Intern Med
|
2015
|
0.78
|
|
97
|
Respiratory motion and cardiac arrhythmia effects on diagnostic accuracy of myocardial delayed-enhanced MR imaging in canines.
|
Radiology
|
2008
|
0.78
|
|
98
|
Stroke prevention in atrial fibrillation.
|
Cardiovasc Drugs Ther
|
2011
|
0.78
|
|
99
|
Economic Outcomes With Anatomical Versus Functional Diagnostic Testing for Coronary Artery Disease.
|
Ann Intern Med
|
2016
|
0.78
|
|
100
|
Ischemia-driven revascularization: demonstrating and delivering a mature procedure in a mature way.
|
Circ Cardiovasc Qual Outcomes
|
2013
|
0.77
|
|
101
|
Response to letter regarding article, "renal dysfunction as a predictor of stroke and systemic embolism in patients with nonvalvular atrial fibrillation: validation of the R2CHADS2 index in the ROCKET AF (Rivaroxaban Once-Daily, Oral, Direct Factor Xa Inhibition Compared With Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation) and ATRIA (Anticoagulation and Risk Factors in Atrial Fibrillation) study cohorts".
|
Circulation
|
2013
|
0.77
|
|
102
|
2013 appropriate utilization of cardiovascular imaging: a methodology for the development of joint criteria for the appropriate utilization of cardiovascular imaging by the American College of Cardiology Foundation and American College of Radiology.
|
J Am Coll Radiol
|
2013
|
0.77
|
|
103
|
The aorta wall of patients presenting to the emergency department with acute myocardial infarction by cardiac magnetic resonance.
|
Atherosclerosis
|
2010
|
0.77
|
|
104
|
Intra-aortic balloon counterpulsation reduces mortality in large anterior myocardial infarction complicated by persistent ischaemia: a CRISP-AMI substudy.
|
EuroIntervention
|
2015
|
0.77
|
|
105
|
Amplatzer vascular plug closure of a subclavian arteriovenous fistula associated with implantable cardioverter-defibrillator implantation.
|
Catheter Cardiovasc Interv
|
2011
|
0.77
|
|
106
|
Peripheral arterial testing before lower extremity amputation among Medicare beneficiaries, 2000 to 2010.
|
Circ Cardiovasc Qual Outcomes
|
2014
|
0.77
|
|
107
|
Limb ischemia: cardiovascular diagnosis and management from head to toe.
|
Curr Cardiol Rep
|
2015
|
0.77
|
|
108
|
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: American College of Cardiology Foundation Appropriate Use Criteria Task Force Society for Cardiovascular Angiography and Interventions American Association for Thoracic Surgery American Heart Association, American Society of Echocardiography American Society of Nuclear Cardiology Heart Failure Society of America Heart Rhythm Society, Society of Critical Care Medicine Society of Cardiovascular Computed Tomography Society for Cardiovascular Magnetic Resonance Society of Thoracic Surgeons.
|
Catheter Cardiovasc Interv
|
2012
|
0.76
|
|
109
|
Hand-held echocardiographic examination of patients with symptoms of acute coronary syndromes in the emergency department: the 30-day outcome associated with normal left ventricular wall motion.
|
Am Heart J
|
2004
|
0.76
|
|
110
|
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, Society of Thoracic Surgeons.
|
J Thorac Cardiovasc Surg
|
2012
|
0.75
|
|
111
|
The search for myocardial protection: is there still hope?
|
J Am Coll Cardiol
|
2007
|
0.75
|
|
112
|
Learning to walk before we run: the mechanics of medical intervention for peripheral arterial disease.
|
J Am Coll Cardiol
|
2011
|
0.75
|
|
113
|
Peripheral arterial disease: an overview of endovascular therapies and contemporary treatment strategies.
|
Rev Cardiovasc Med
|
2006
|
0.75
|
|
114
|
Prosthetic valve thrombosis: when and how should we lyse?
|
JACC Cardiovasc Imaging
|
2013
|
0.75
|
|
115
|
Non-ST-segment elevation acute coronary syndromes: targeted imaging to refine upstream risk stratification.
|
Circ Cardiovasc Imaging
|
2012
|
0.75
|
|
116
|
Rebuttal: the CTO "no-controversy" controversy: should the field of CTO-PCI be allowed to expand?
|
Catheter Cardiovasc Interv
|
2012
|
0.75
|
|
117
|
Serious infection after acute myocardial infarction: incidence, clinical features, and outcomes.
|
JACC Cardiovasc Interv
|
2012
|
0.75
|
|
118
|
Reply: To PMID 23062539.
|
J Am Coll Cardiol
|
2013
|
0.75
|
|
119
|
Screening for structural heart disease: time to stop listening and start looking.
|
Am Heart J
|
2003
|
0.75
|
|
120
|
Next-generation drug-eluting stents: a spirited step forward or more of the same.
|
JAMA
|
2008
|
0.75
|
|
121
|
Point-of-Care Warfarin Monitoring in the ROCKET AF Trial.
|
N Engl J Med
|
2016
|
0.75
|
|
122
|
Reply: To PMID 22954239.
|
J Am Coll Cardiol
|
2013
|
0.75
|
|
123
|
Appropriate use of cardiac computed tomography: applying the yardstick to clinical practice.
|
J Cardiovasc Comput Tomogr
|
2008
|
0.75
|
|
124
|
The value proposition in percutaneous coronary intervention.
|
JACC Cardiovasc Interv
|
2013
|
0.75
|
|
125
|
Regarding "stroke and death after carotid endarterectomy and carotid artery stenting with and without high risk criteria".
|
J Vasc Surg
|
2011
|
0.75
|
|
126
|
Practice Variation Among Hospitals in Revascularization Therapy and Its Association With Procedure-related Mortality.
|
Med Care
|
2016
|
0.75
|
|
127
|
Trade-offs and toss-ups: making revascularization decisions in carotid artery disease.
|
J Am Coll Cardiol
|
2011
|
0.75
|
|
128
|
High risk percutaneous coronary intervention and intra-aortic balloon pumps: when is the safety net needed?
|
Circ Cardiovasc Qual Outcomes
|
2012
|
0.75
|
|
129
|
The devil is in the details: the need for integrated cardiovascular data for performance measures and feedback.
|
Circulation
|
2014
|
0.75
|
|
130
|
A case of mistaken identity: persistent sciatic artery stenosis as a cause of critical limb ischemia.
|
Catheter Cardiovasc Interv
|
2011
|
0.75
|
|
131
|
Relation of ventricular premature complexes during recovery from a myocardial perfusion exercise stress test to myocardial ischemia.
|
Am J Cardiol
|
2006
|
0.75
|
|
132
|
Adenosine stress cardiac magnetic resonance imaging.
|
Am Heart J
|
2004
|
0.75
|
|
133
|
Relationship of sustained ventricular tachyarrhythmias to outcomes in patients undergoing primary percutaneous coronary intervention with varying underlying baseline risk.
|
Am Heart J
|
2011
|
0.75
|
|
134
|
Variations in practice and outcomes in patients undergoing primary percutaneous coronary intervention in the United States and Canada: insights from the Assessment of Pexelizumab in Acute Myocardial Infarction (APEX AMI) trial.
|
Am Heart J
|
2012
|
0.75
|
|
135
|
Luftsichel sign upperlobe collapse.
|
Am J Med
|
2002
|
0.75
|
|
136
|
Highlights from the American College of Cardiology Annual Scientific Sessions 2004: March 9-12, 2004.
|
Am Heart J
|
2004
|
0.75
|
|
137
|
ACC/AATS/AHA/ASE/ASNC/HRS/SCAI/SCCT/SCMR/STS 2017 Appropriate Use Criteria for Multimodality Imaging in Valvular Heart Disease: A Report of the American College of Cardiology Appropriate Use Criteria Task Force, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.
|
J Am Soc Echocardiogr
|
2017
|
0.75
|
|
138
|
Cardiac imaging impaired by a silicone breast implant.
|
Clin Nucl Med
|
2005
|
0.75
|
|
139
|
The impact of processes of care on myocardial infarct size in patients with ST-segment elevation myocardial infarction: observations from the CRISP-AMI trial.
|
Clin Cardiol
|
2014
|
0.75
|
|
140
|
Evidence-based therapies and mortality in patients hospitalized in December with acute myocardial infarction.
|
Ann Intern Med
|
2005
|
0.75
|
|
141
|
Integrating ancillary studies in a large clinical trial: the design and rationale of the APEX library.
|
Contemp Clin Trials
|
2008
|
0.75
|
|
142
|
Appropriateness of percutaneous coronary intervention: a review.
|
Curr Cardiol Rep
|
2013
|
0.75
|
|
143
|
Training cardiovascular specialists in imaging: a curriculum based on fundamental concepts required for multimodal imaging.
|
Am Heart J
|
2007
|
0.75
|
|
144
|
Promise of factor Xa inhibition in atrial fibrillation.
|
Curr Cardiol Rep
|
2012
|
0.75
|
|
145
|
Risk Factors for Major Bleeding in Rivaroxaban Users With Atrial Fibrillation.
|
J Am Coll Cardiol
|
2016
|
0.75
|
|
146
|
The editor's roundtable: management and treatment of non-ST-segment elevation in acute coronary syndromes.
|
Am J Cardiol
|
2008
|
0.75
|
|
147
|
Combined use of warfarin and oral P2Y12 inhibitors in patients with atrial fibrillation and acute coronary syndrome.
|
Clin Cardiol
|
2013
|
0.75
|
|
148
|
ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 Appropriateness Criteria for Stress Echocardiography. A report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine.
|
Catheter Cardiovasc Interv
|
2008
|
0.75
|
|
149
|
Interventional treatment of hypertension: a new paradigm.
|
Curr Cardiol Rep
|
2013
|
0.75
|